ReShape Lifesciences Inc. (OTCMKTS:RSLS – Get Rating) CEO Barton P. Bandy sold 11,309 shares of the business’s stock in a transaction that occurred on Wednesday, June 1st. The shares were sold at an average price of $0.95, for a total transaction of $10,743.55. Following the transaction, the chief executive officer now owns 796,214 shares of […]
ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) and MiMedx Group (NASDAQ:MDXG – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability. Profitability This table compares ReShape Lifesciences and MiMedx Group’s […]